- Author:
Sowmya NARAYANAN
1
;
Fionna A SURETTE
;
Young S HAHN
Author Information
- Publication Type:Review
- Keywords: Liver; Immunity; Fatty liver
- MeSH: Cardiovascular Diseases; Fatty Liver; Fibrosis; Insulin Resistance; Lipid Metabolism; Liver; Metabolic Diseases; Metabolic Networks and Pathways; Non-alcoholic Fatty Liver Disease*
- From:Immune Network 2016;16(3):147-158
- CountryRepublic of Korea
- Language:English
- Abstract: The liver lies at the intersection of multiple metabolic pathways and consequently plays a central role in lipid metabolism. Pathological disturbances in hepatic lipid metabolism are characteristic of chronic metabolic diseases, such as obesity-mediated insulin resistance, which can result in nonalcoholic fatty liver disease (NAFLD). Tissue damage induced in NAFLD activates and recruits liver-resident and non-resident immune cells, resulting in nonalcoholic steatohepatitis (NASH). Importantly, NASH is associated with an increased risk of significant clinical sequelae such as cirrhosis, cardiovascular diseases, and malignancies. In this review, we describe the immunopathogenesis of NASH by defining the known functions of immune cells in the progression and resolution of disease.